Comparison |
| Application |
| Pneumonia Vaccine | Rotavirus Vaccine |
| Container Type |
| Prefilled Syringe | Single-Dose Tube |
| Country of Origin |
Unknown | United States | United States |
| Dosage Form |
| Injection | Solution |
| Generic Drug Code |
| 43859 | 26500 |
| Generic Drug Name |
| Pneumococcal 23 Vaccine Polyvalent | Rotavirus Vaccine, Live, Oral Pentavalent |
| NDC Number |
| 00006483703 | 00006404741 |
| Product Dating |
| McKesson Acceptable Dating: we will ship >= 180 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Storage Requirements |
| Requires Refrigeration | Requires Refrigeration |
| Strength |
| 25 mcg / 0.5 mL | |
| Type |
| Intramuscular or Subcutaneous | Oral |
| UNSPSC Code |
| 51201615 | 51201618 |
| User |
| Indicated for People 50 Years of Age and Older | Indicated for People 6 to 32 Weeks of Age |
| Volume |
| 0.5 mL | 2 mL |
| Features and Benefits |
|
- PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine
- PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease
- Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons
- Store unopened and opened vials at 2° - 8°C (36° - 46°F)
|
- The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
- 10 individually pouched single dose tubes
- Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
|
